(MENAFN- PR Newswire) Plans initiated to build new CLIA-certified laboratory for early detection of treatable genetic disorders in newborns Expanding in-house clinical testing and research ...
Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する